3-(6-Chloro-1-oxo-1H-pyrrolo[3,4-c]pyridin-2(3H)-yl)piperidine-2,6-dione, 98%, 1g

(2E)-1-(3-chlorophenyl)-3-(3-methylphenyl)prop-2-en-1-one, 95.0%, 2g

4-(2-chlorobenzoyl)-8-methyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

3,4,5-Trimethoxytoluene, 95.0%, 500g

tert-Butyl 1-isobutylpiperidin-4-ylcarbamate, 95.0%, 500mg

2-(Pyridin-2-yl)phenol, 95.0%, 5g

n-(2-Morpholinoethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 97%, 10g

Microliter syringe MICROLITER® series 7000 Point type 2, 2.0 µl, 7002 KH, 1 piece

Bismuth oxide 99.9995% 50 g

2-Chloro-3-fluoro-4-(methylthio)pyridine, 95%, 5g

2-(1-{[(tert-Butoxy)carbonyl]amino}cyclopropyl)acetic acid, 95%, 10g

TLC Plates CEL 300, 10 x 20 cm, 50 Piece(s)

7-Bromo-2,3,4,5-tetrahydro-1H-benzo[c]azepin-1-one, 97%, 100mg